Trial to assess Acute Kidney Injury risk prediction technology starts at MFT
A pioneering clinical trial of new technology to predict the risk of patients developing Acute Kidney Injury (AKI) has begun at MFT.
Read more
A pioneering clinical trial of new technology to predict the risk of patients developing Acute Kidney Injury (AKI) has begun at MFT.
Read more
A leading MFT cancer professor MFT features in a documentary following TV presenter Julia Bradbury’s personal breast cancer journey.
Read more
A world-first genetic test, developed in Manchester, that could save the hearing of hundreds of babies each year has been successfully piloted in the NHS.
Read more
The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.
Read more
Children in the UK will be able to receive Palforzia – a life-changing oral treatment for peanut allergies – as NHS standard of care following approval for use by NICE.
Read more
The first participants have been involved in a study onboard Greater Manchester’s new state-of-the-art Research Van.
Read more
People who were hospitalised with COVID-19 and continued to experience symptoms at five months show limited further recovery one year after hospital discharge, according to latest research.
Read more
Levels of a fungus hazardous to patients with respiratory disease are more abundant in rooms with outside facing windows during the summer months, MFT researchers have found.
Read more